[1]
Paoletti, D. and Giorgi, S. 2015. Bevacizumab in the treatment of metastatic colorectal cancer: the RFOM in the experience of the A.O. University of Siena. Global and Regional Health Technology Assessment. 2, 1 (Mar. 2015), 61–62. DOI:https://doi.org/10.33393/grhta.2015.326.